REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 105 filers reported holding REVANCE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,601 | +323.3% | 1,248,586 | +438.7% | 0.11% | +303.7% |
| Q1 2023 | $7,465 | -99.5% | 231,776 | +144.7% | 0.03% | +440.0% |
| Q1 2016 | $1,653,000 | -92.1% | 94,700 | -84.5% | 0.01% | -92.1% |
| Q4 2015 | $20,830,000 | +250.8% | 609,768 | +205.6% | 0.06% | +250.0% |
| Q3 2015 | $5,938,000 | -7.8% | 199,544 | -0.9% | 0.02% | +5.9% |
| Q2 2015 | $6,439,000 | +19.6% | 201,366 | -27.7% | 0.02% | +21.4% |
| Q3 2014 | $5,385,000 | -60.5% | 278,607 | -30.6% | 0.01% | -12.5% |
| Q2 2014 | $13,646,000 | +249.6% | 401,366 | +223.9% | 0.02% | +77.8% |
| Q1 2014 | $3,903,000 | – | 123,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |